Category: Biotech

Absci and Almirall have recently expanded their collaboration, which is a 21-month-old partnership based on artificial intelligence (AI), to focus on the development and commercialization of AI-designed therapeutics for chronic and debilitating skin diseases. The Barcelona-based drug developer, Almirall, has selected a second target for development under this collaboration. The companies have successfully generated AI-designed, […]

Hatteras Venture Partners, based in Durham, N.C., recently closed its Hatteras Venture Partners VII (HVP VII) and Hatteras Opportunity Fund I, LP (HOF I), raising over $200 million from limited partners. This milestone coincided with the investment in its 100th portfolio company and marked the 25th year of the company’s operation. Notably, the firm focuses […]

Io Biotech, a NASDAQ-listed clinical-stage biotech firm specializing in cancer vaccines, recently disclosed its second-quarter financials, focusing on the pivotal Phase 3 trial results of its lead cancer vaccine candidate, Cylembio®. Despite showing a clinical benefit by enhancing progression free survival in advanced melanoma, the trial narrowly missed the statistical significance required for regulatory approval. […]

Skin cancer, particularly melanoma, has traditionally been treated with surgery, but recent advancements in therapies such as checkpoint inhibitors have significantly improved survival rates. Melanoma vaccines are emerging as a promising treatment option, especially when combined with other cancer drugs. Melanoma arises from melanocytes, the pigment-producing cells in the skin, and its uncontrolled growth can […]

Bayer and Kumquat Biosciences have recently formed an exclusive global partnership to develop and commercialize Kumquat’s KRAS G12D inhibitor. Under this agreement, Kumquat will lead the Phase Ia study, with Bayer taking over subsequent development and commercialization efforts. The U.S. FDA has cleared Kumquat’s investigational new drug for the KRAS G12D inhibitor, signaling a significant […]

Born out of China’s elite Tsinghua University in August 2023, Robotera is the breakout humanoid robotics startup turning heads worldwide. Armed with bleeding-edge AI, precision mechatronics, and deep robotics R&D straight from one of the nation’s most prestigious tech powerhouses, this spinoff has rocketed from lab project to global contender—fast becoming one of the hottest […]

Bayer and Kumquat Biosciences have initiated a collaboration aimed at developing Kumquat’s KRAS G12D inhibitor, targeting pancreatic, colorectal, and lung cancers. This partnership, with the potential to generate over $1.3 billion for Kumquat, marks a significant milestone in advancing precision oncology treatments. The FDA recently approved Kumquat’s investigational new drug application for clinical trials of […]

Researchers have harnessed the power of artificial intelligence to revolutionize drug design by creating a new AI tool called PepMLM. This innovative tool is capable of designing small molecules that can bind to and break down disease-related proteins in the body, even when the structure of these proteins is unknown. The implications of this breakthrough […]

Chronic fatigue syndrome (CFS) is a debilitating condition affecting millions of Americans, characterized by persistent fatigue, post-exertional malaise, sleep disturbances, cognitive issues, and more. For years, the lack of objective diagnostic tools has led to delays in diagnosis and challenges in accessing appropriate care. However, recent research led by Anne Gardella from Cornell University has […]

The College of Biological & Environmental Sciences (COCIBA) at Universidad San Francisco de Quito (USFQ) embodies a diverse range of disciplines including Biology, Biotechnology, Ecology, and Natural Resource Management. With a faculty of over 25 full-time professors and researchers, and 300 undergraduate students, COCIBA provides a stimulating environment for education and research. The programs offered […]

The Jamaica Banana Board (JBB) has integrated tissue culture technology into its operations to fortify the banana sector against diseases and environmental challenges. Through collaboration with international partners, the JBB has acquired diverse banana varieties that are preserved in the lab for rapid multiplication in case of emergencies. This approach aims to support local farmers […]

Selecting cells with desired characteristics for further development is a critical aspect of cell culture and research workflows. Traditional cell-selection technologies often lack the sensitivity needed to maintain cell health and proliferative capacity, leading to limitations in research progress. The CellCelector from Sartorius offers a solution by automating the identification and picking of cells with […]

The landscape of gene editing and its potential application in modifying human embryos has reignited discussions and controversies surrounding the creation of genetically modified babies. Following the controversial case of a Chinese scientist who engineered the birth of gene-edited babies in 2018, renewed interest in gene-editing technologies has emerged. While mainstream scientific bodies advocate for […]

The realm of biotechnology, particularly in herbal sciences, is witnessing a significant surge in innovation and breakthroughs. From the intriguing potential of herbal teas in combating cancer to the promise of biotech companies revolutionizing neuroscience, the landscape is abuzz with activity. Somerset, a hub for herbal biotechnology, is at the forefront of these advancements. Companies […]

Monoclonal antibodies have revolutionized the field of biotechnology and are widely used in various therapeutic applications. Monitoring monoclonal antibody therapy is crucial for ensuring its effectiveness in treating diseases like cancer. Strategies in protein engineering have been developed to overcome clearance liabilities associated with monoclonal antibodies, enhancing their efficacy. Hybridoma technology plays a pivotal role […]

The controversial quest to create gene-edited babies initiated by a Chinese scientist in 2018 has sparked renewed interest in the field of gene editing and human reproduction. While mainstream scientific organizations advocate for cautious exploration of gene-editing technologies with a strong emphasis on ethical considerations, a new wave of enthusiasts, including venture capitalists and entrepreneurs, […]

Dacian glycoengineering platforms are instrumental in advancing research on protein glycosylation, a vital aspect of biological processes. These platforms offer innovative approaches to glycoproteomics and glycoengineering, enabling a deeper understanding of protein functions and interactions. The Dacian Kingdom, known for its historical significance as Europe’s Ancient Powerhouse, continues to inspire modern research and development in […]

The Chuvash enzymatic cascade development is a significant area of study in biotechnology that involves understanding and manipulating enzymatic reactions for various applications. Enzymes play a crucial role in catalyzing biochemical reactions, and the development of enzymatic cascades can lead to the synthesis of chiral amino alcohols from compounds like L-lysine. These cascades involve a […]

The Burkinabe herbal biotech incubator is a significant initiative in Burkina Faso, aiming to harness the power of traditional medicinal knowledge through modern biotechnology. This project involves the development of enhanced traditional medicines at the University Joseph Ki-Zerbo, showcasing a fusion of age-old healing practices with cutting-edge scientific advancements. The utilization of solar and electric […]

In the world of biotechnology, Bohemian synthetic biology stands out as a fascinating and innovative field that is revolutionizing science and medicine. Through the creation of programmable organisms and the designing of new life forms, synthetic biology is pushing the boundaries of what is possible in regenerative medicine and genetic engineering. This interdisciplinary approach combines […]

The Ainu people, an indigenous group in Japan, have recently garnered attention from scientists who unveiled surprising genetic origins of this unique population. Amidst this cultural exploration, the town of Shiranuka has been highlighted for its rich Ainu heritage, shedding light on the DNA history and genetic roots of the Ainu people. Despite past suppression, […]

Artificial intelligence (AI) continues to revolutionize the biotech industry with the emergence of cutting-edge technologies and innovations. One significant development is the rise of digital twins, which are virtual representations of physical entities or systems. Companies like Duality AI are leveraging digital twin technology to create FalconEditor, a simulation platform based on Unreal Engine. These […]

The recent imposition of an additional 25% tariff by US President Donald Trump on India, in response to its continued purchase of Russian oil, has significant implications for the biotech sector and global trade dynamics. This move marks a notable escalation in the ongoing trade tensions between the two countries and raises concerns about the […]

The influx of multinational pharmaceutical companies into China has provided a lifeline for many local biotech companies facing financial hardships. Chinese biotechs have increasingly turned to out-licensing deals with international firms to secure funding and sustain their operations. A significant number of these companies were on the verge of collapse due to financial constraints before […]

The month of July 2025 witnessed significant funding rounds in the biotech industry, with companies such as Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics securing substantial investments across private and public funding categories. Particularly, these companies made headlines for their remarkable fundraising activities, emphasizing the ongoing financial support within the biotech sector. Private Biotech […]

The landscape of cross-border partnering in the life sciences sector, especially between Chinese biotech firms and their US/European counterparts, has significantly transformed in the past decade. This transformation has been driven by regulatory enhancements, increased innovation, and the changing dynamics of capital markets, leading to a surge in both volume and value of deals. Notably, […]

Biomedical innovators and biohacking firms are increasingly drawn to Montana as a promising frontier for experimental medical treatments, seeking to establish the state as a hub for therapies not yet approved by the FDA. With new state laws in place, companies are eyeing the potential to offer experimental drugs and treatments, leveraging a unique legislative […]

Krystal Biotech is scheduled to release its latest quarterly earnings report on August 4, 2025, with analysts forecasting an earnings per share (EPS) of $1.29. Investors are keen to see if the company surpasses this estimate and provides positive guidance for future growth, as such announcements can significantly impact stock prices. Notably, stock performance can […]

Advancements in genome sequencing have revolutionized the understanding and detection of genetic variations within the human genome. A significant breakthrough lies in variant calling, the process of identifying and documenting genetic variances like SNPs and indels from sequencing data. Recent research has introduced the Platinum Pedigree benchmark, a comprehensive truth-set of genomic variation that encompasses […]

Vertex Pharmaceuticals Inc.’s stock has experienced a decline following the release of Phase 2 study data on its investigational pain signal inhibitor, VX-993. The study did not show a statistically significant improvement in pain relief compared to a placebo, leading to the decision not to advance VX-993 for acute pain treatment. Despite this setback, Vertex […]

The beauty industry is witnessing a surge in regenerative treatments that claim to revolutionize skin renewal processes. In a luxurious dome in New York City, facialist Pietro Simone introduces the Exosome Dome, a revolutionary treatment combining light therapy, environmental cleansing, energetic healing, and exosome biotechnology. These cutting-edge therapies aim to enhance cellular communication pathways and […]

More than a century ago, Dr. William B. Coley laid the groundwork for modern immunotherapy by injecting cancer patients with bacterial toxins in an effort to reduce tumors. In a groundbreaking development, researchers in Japan have now gone a step further by targeting cancer in mice without relying on the immune system. They have introduced […]

Securing funding for biotechnology and life sciences startups in the Front Range can be a daunting task, prompting industry leaders to explore creative solutions amidst the current federal funding turmoil. Federal Small Business Innovation Research grants have historically supported many companies, contributing significantly to Colorado’s economy with $2.3 billion in annual output and 12,000 jobs. […]

Alcon has introduced Tryptyr (acoltremon ophthalmic solution) 0.003% in the United States for managing dry eye disease (DED), following its approval by the US Food and Drug Administration in late May 2025. The product is designed for the relief of both the signs and symptoms associated with DED and is packaged in single-dose vials, with […]

Recursion Pharmaceuticals is scheduled to announce its quarterly earnings on August 5, 2025, with analysts projecting an earnings per share (EPS) of $-0.35. The market eagerly anticipates the company’s performance, hoping for results that exceed expectations and positive guidance for the upcoming quarter. It is crucial for investors, especially newcomers, to recognize that guidance provided […]

Ionis Pharmaceuticals, a U.S.-based biotech firm with a market cap of $6.8 billion, specializes in developing RNA-targeted therapeutics for genetic and biochemical disorders. Despite collaborations with major pharmaceutical companies, Ionis made waves with the independent launch of Tryngolza, a drug targeting familial chylomicronemia syndrome, which saw impressive commercial success post-launch. The stock of Ionis (IONS) […]

GenScript Biotech Corporation, headquartered in Piscataway, N.J., has recently achieved an upgrade in its MSCI ESG rating from A to AA. This notable advancement by MSCI, a renowned index provider, highlights GenScript’s outstanding performance in product safety, quality, human capital development, and advancements in environmental and governance practices. The AA rating positions GenScript as a […]

Alnylam Pharmaceuticals Inc. continues to impress investors in the biotechnology sector with its exceptional performance, surpassing market expectations. The company’s recent second-quarter earnings report and optimistic 2025 forecast have propelled its stock to a 52-week high, reflecting its robust position in the competitive landscape driven by innovative treatments. In the second quarter of 2025, Alnylam […]

The intricate Notch signaling pathway is crucial in dictating cell fate, notably in T cell development and function. Replicating this complex, contact-dependent pathway in lab settings has historically posed significant challenges. However, a breakthrough has emerged as a team of researchers from Boston Children’s Hospital and Harvard Medical School leveraged AI-derived tools to engineer a […]

Aging is a multifaceted process, characterized by diverse health trajectories among individuals. Frailty, a state where the body loses its robustness and becomes more susceptible to various stresses like falls and infections, significantly escalates the risks of hospitalization and mortality. The comprehension of frailty’s varying impact on individuals is pivotal for advancing therapies related to […]

Molecular diagnostics play a pivotal role in expanding patient access to precision oncology therapies. The utilization of rapid and automated Next-Generation Sequencing (NGS) solutions in companion diagnostics (CDx) leverages advanced technologies to accelerate the availability of tailored treatments. Companies like Oncomine are at the forefront, offering trusted NGS CDx solutions that cover a spectrum of […]

Molecular diagnostics, a cutting-edge field in biotechnology, employs techniques like PCR and real-time PCR to analyze genetic material for disease detection. Laboratories worldwide are adopting automated systems for faster and more accurate results. These advancements have significantly impacted healthcare, especially in infectious diseases and cancer management. One key area where molecular diagnostics excel is in […]

In the biotech industry, companies like PharmaManufacturer and Beacon MedTech are offering clinical and commercial-scale solutions for aseptic and parenteral manufacturing needs, positioning themselves as key players in the field. PharmaManufacturer emphasizes being a Pharma CMO partner for those seeking lyophilization services, while Beacon MedTech specializes in custom medical component manufacturing for biomedical applications. These […]

In a significant shift in investor focus, precision agriculture (ag) startups have outpaced ag biotech ventures in securing venture capital for the first time since the third quarter of 2017. According to data from PitchBook, precision ag companies raised $580 million across 36 deals in Q2, 2025, marking a remarkable 71.2% increase in funding despite […]

The biotech industry in San Diego is facing challenging times, with a scarcity of jobs and capital creating uncertainty among professionals like Vince Kato. Despite the optimism stemming from venture capital returns and the strong performance of local biotech stocks, the reality on the ground is harsh for many individuals. Kato, who was laid off […]

In the realm of biotechnology, companies like Vertex and Santa Cruz Biotechnology are at the forefront of cutting-edge research and development, particularly in the fields of cell and gene therapy. Vertex, known for its innovative approaches, is actively engaged in creating novel treatments for genetic diseases through meticulous research efforts. This dedication to innovation has […]

Biotechnology, a field at the cutting edge of science and technology, has witnessed remarkable breakthroughs over the years. From understanding the basics of biotechnology to exploring its limitless applications, this sector has been pivotal in driving advancements and innovations across various industries. As we delve into the world of biotech, it becomes evident that the […]

Allogene, in its pivotal Phase II trial, is evaluating cemacabtagene ansegedleucel, a CAR T therapy designed for treating large B-cell lymphoma. Within this trial, the company had incorporated ALLO-647 as a preparative lymphodepletion therapy. Unfortunately, a patient enrolled in the ALPHA3 trial of cemacabtagene ansegedleucel passed away. The patient’s death was not directly linked to […]

Last week brought a flurry of exciting news in the pharmaceutical world. US biotech company Celcuity saw a remarkable 180% increase in its stock value following positive Phase III data for its cancer drug candidate gedatolisib. Another US drugmaker, Madrigal Pharmaceuticals, struck a licensing deal with China’s CSPC Pharma for the rights to a GLP-1 […]

Artbio, a clinical-stage radiopharmaceutical biotech company, has secured a significant $132 million Series B funding round with the backing of Qatar’s sovereign wealth fund, the Qatar Investment Authority (QIA). This marks QIA’s first investment in Artbio, highlighting the fund’s strategic focus on supporting innovative biotech companies. The funding round was led by prominent investors including […]

Northway Biotech, a renowned CDMO specializing in protein-based biologics and gene therapies, has joined forces with Diorasis Therapeutics to advance AAV gene therapy for the treatment of glaucoma. Leveraging Northway Biotech’s extensive experience in cell line development, process optimization, and cGMP manufacturing, the partnership aims to establish a scalable production process for DTx’s lead gene […]

France has emerged as a hub for biotech startups, attracting investments and attention from global investors and researchers alike. The NATO Innovation Fund recently co-led a $35 million Series A round into PortalBiotech, a U.K.-based startup claiming to have developed the world’s first platform for full-length genetic sequencing. This investment highlights the growing interest in […]

As data volumes continue to skyrocket, edge computing is emerging as a crucial shift in how biotech enterprises build and operate their infrastructure. The combination of cloud and edge computing is revolutionizing real-time intelligence, enabling organizations to achieve unmatched speed, lower latency, and localized action. With global spending on edge computing projected to reach nearly […]

In the ever-evolving world of pharmaceutical manufacturing, staying abreast of the latest trends and insights is crucial for industry professionals. The Emerging Market Outsourcing Report – Q2 2025 provides a comprehensive analysis of the pharmaceutical outsourcing industry, offering valuable information on emerging market contract service agreements, mergers, acquisitions, and financing in the CMO sector. This […]

The British government announced on Monday that AustralianSuper, a pension giant, is planning to invest an additional 8 billion pounds ($10.15 billion) in the UK, bringing its total investment in the country to over 18 billion pounds. This significant investment comes at a pivotal time for the UK biotech sector, which saw a remarkable 94% […]

In the wake of the recent NIH funding cuts, the biotech industry is facing unprecedented challenges that threaten the very foundation of medical innovation. The NIH has long been a crucial source of support for early-stage research and development, providing essential funding for groundbreaking discoveries and clinical trials. With the drastic reduction in funding, biotech […]

Venture capital firm Boson Ventures is highlighting the missed opportunities for Australian biotechnology startups in tapping into China’s rapidly growing pharmaceutical market. With China’s transition from being dependent on Western drugs to becoming a key player in global pharmaceutical innovation, Australian companies are encouraged to explore collaborations in the thriving Chinese biotech ecosystem. Betty Zhang, […]